Evidence map›Paper›PMID 29734773›Full record

ReviewMolecules (Basel, Switzerland)2018

Efficient Anaerobic Digestion of Microalgae Biomass: Proteins as a Key Macromolecule.

Jose Antonio Magdalena, Mercedes Ballesteros, Cristina González-Fernandez

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Enhancement of euryhaline3 Biotech · 2021
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jose Antonio MagdalenaBiotechnological Processes Unit, IMDEA Energy, 28040 Madrid, Spain. joseantonio.magdalena@imdea.org.
Mercedes BallesterosBiotechnological Processes Unit, IMDEA Energy, 28040 Madrid, Spain. mercedes.ballesteros@imdea.org.
Cristina González-FernandezBiotechnological Processes Unit, IMDEA Energy, 28040 Madrid, Spain. cristina.gonzalez@imdea.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biogas generation is the least complex technology to transform microalgae biomass into bioenergy. Since hydrolysis has been pointed out as the rate limiting stage of anaerobic digestion, the main challenge for an efficient biogas production is the optimization of cell wall disruption/hydrolysis. Among all tested pretreatments, enzymatic treatments were demonstrated not only very effective in disruption/hydrolysis but they also revealed the impact of microalgae macromolecular composition in the anaerobic process. Although carbohydrates have been traditionally recognized as the polymers responsible for the low microalgae digestibility, protease addition resulted in the highest organic matter solubilization and the highest methane production. However, protein solubilization during the pretreatment can result in anaerobic digestion inhibition due to the release of large amounts of ammonium nitrogen. The possible solutions to overcome these negative effects include the reduction of protein biomass levels by culturing the microalgae in low nitrogen media and the use of ammonia tolerant anaerobic inocula. Overall, this review is intended to evidence the relevance of microalgae proteins in different stages of anaerobic digestion, namely hydrolysis and methanogenesis.

Indexed as

AmmoniaAnaerobiosisBiofuelsBiomassBioreactorsCarbohydratesCellulasesCell WallCulture MediaFermentationHydrolysisMethaneMicroalgaeMicrobial ConsortiaNitrogenPeptide HydrolasesAmmoniaBiofuelsCarbohydratesCellulasesCulture MediaMethaneNitrogenPeptide Hydrolasesanaerobic digestionbiogasinhibitionmicroalgaeproteins

Identifiers

PMID29734773
PMCPMC6099730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.